The background, role and approach for development of a controlled human infection model for nontyphoidal Salmonella by MacLennan, CA

Outer membrane vesicle vaccines by Micoli, F, MacLennan, CA

The immunology of infection by Gilchrist, JJ, MacLennan, CA

Age- and sex-related changes in hematological parameters in healthy Malawians by Mandala WL, Gondwe EN, MacLennan JM, Molyneux ME, MacLennan CA

Get full text

HIV infection compounds the lymphopenia associated with cerebral malaria in Malawian children by Mandala WL, Gondwe EN, Nyirenda TS, Drayson M, Molyneux ME, MacLennan CA

Get full text

Critical needs in advancing Shigella vaccines for global health by MacLennan, CA, Talaat, KR, Kaminski, RW, Cohen, D, Riddle, MS, Giersing, BK

Incidence of Salmonella bacteremia among young children in sub-Saharan Africa: MAL055 RTS, S/AS01 Salmonella Ancillary Study by MacLennan, CA, Wiegand, R, Westercamp, N, Kariuki, S, Clinical Trials Partnership Committee Investigators

Typhoid conjugate vaccines and enteric fever control: where to next? by Steele, AD, Carey, ME, Kumar, S, MacLennan, CA, Ma, L-F, Diaz, Z, Zaidi, AKM

IgG Serum Antibodies to Shigella sonnei Lipopolysaccharide Are Inversely Associated with the Incidence of Culture-Proven S. sonnei Shigellosis in Israeli Children and Adolescents by Asato, V, Bassal, R, Meron-Sudai, S, Goren, S, Keinan-Boker, L, MacLennan, CA, Cohen, D

Cross-sectional study of IgG antibody levels to invasive nontyphoidal Salmonella LPS O-antigen with age in Uganda by Stockdale, L, Nalwoga, A, Nash, S, Elias, S, Asiki, G, Kusemererwa, S, Gilchrist, JJ, Newton, R, MacLennan, CA

The role of sapA and yfgA in susceptibility to antibody-mediated complement-dependent killing and virulence of Salmonella enterica serovar Typhimurium by Ondari, EM, Heath, JN, Klemm, EJ, Langridge, G, Barquist, L, Goulding, DA, Clare, S, Dougan, G, Kingsley, RA, MacLennan, CA

Contribution of factor H-Binding protein sequence to the cross-reactivity of meningococcal native outer membrane vesicle vaccines with over-expressed fHbp variant group 1 by Marini, A, Rossi, O, Aruta, MG, Micoli, F, Rondini, S, Guadagnuolo, S, Delany, I, Henderson, IR, Cunningham, AF, Saul, A, MacLennan, CA, Koeberling, O

Gonococcal vaccines: Public health value and preferred product characteristics; report of a WHO global stakeholder consultation, January 2019 by Gottlieb, SL, Ndowa, F, Hook, EW, Deal, C, Bachmann, L, Abu-Raddad, L, Chen, X-S, Jerse, A, Low, N, MacLennan, CA, Petousis-Harris, H, Seib, KL, Unemo, M, Vincent, L, Giersing, BK

Short Vi-polysaccharide abrogates T-independent immune response and hyporesponsiveness elicited by long Vi-CRM197 conjugate vaccine by Micoli, F, Bjarnarson, SP, Arcuri, M, Aradottir Pind, AA, Magnusdottir, GJ, Necchi, F, Di Benedetto, R, Carducci, M, Schiavo, F, Giannelli, C, Pisoni, I, Martin, LB, Del Giudice, G, MacLennan, CA, Rappuoli, R, Jonsdottir, I, Saul, A

Risk of nontyphoidal Salmonella bacteraemia in African children is modified by STAT4 by Gilchrist, JJ, Rautanen, A, Fairfax, BP, Mills, TC, Naranbhai, V, Trochet, H, Pirinen, M, Muthumbi, E, Mwarumba, S, Njuguna, P, Mturi, N, Msefula, CL, Gondwe, EN, MacLennan, JM, Chapman, SJ, Molyneux, ME, Knight, JC, Spencer, CCA, Williams, TN, MacLennan, CA, Scott, JAG, Hill, AVS

Outer membrane protein size and LPS O-antigen define protective antibody targeting to the Salmonella surface by Domínguez-Medina, CC, Pérez-Toledo, M, Schager, AE, Marshall, JL, Cook, CN, Bobat, S, Hwang, H, Chun, BJ, Logan, E, Bryant, JA, Channell, WM, Morris, FC, Jossi, SE, Alshayea, A, Rossiter, AE, Barrow, PA, Horsnell, WG, MacLennan, CA, Henderson, IR, Lakey, JH, Gumbart, JC, López-Macías, C, Bavro, VN, Cunningham, AF